EUVIMEDEUVIMED entdecken
Crossref

Computer‐Aided Algorithmic Approaches to Drug Development for Multi‐Mutant HIV‐1 Reverse Transcriptase

Akmal Zubair, Muhammad Ali, Mahmoud M Hessien

Clinical Pharmacology in Drug Development · 2026

DOI: 10.1002/cpdd.1585 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinical Pharmacology in Drug Development, 2026. Verfasst von Akmal Zubair und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biotechnology, Quaid-i-Azam University, Islamabad, Pakistan. Hauptthemen laut MEDLINE: HIV Reverse Transcriptase, Reverse Transcriptase Inhibitors, HIV-1, Drug Development. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 68 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Non‐nucleoside reverse transcriptase inhibitors (NNRTIs) inhibit the activity of the reverse transcriptase enzyme in HIV, representing a significant advancement in antiviral therapy. The emergence of antiviral‐resistant strains of HIV‐1 poses a substantial challenge in the treatment of HIV. This study presents an innovative virtual screening method that integrates a drug screening approach based on molecular structure to identify potential inhibitors for drug‐resistant HIV‐1 strains. Wild‐type reverse transcriptase and a proposed multi‐mutant variant were identified as target proteins for structure‐based virtual screening. For better interpretation, selected compounds were used for molecular docking and molecular dynamics simulation. Six compounds with strong binding affinities were identified from the Comprehensive Marine Natural Products Database (CMNPD) as potential NNRTI candidates. In CMNPD database six compounds were identifed that have potential activity against the multi‐mutant reverse transcriptase enzyme of HIV‐1. Molecular modeling studies revealed that the highest‐ranking compound (CMNPD370) binds persistently and with significant affinity to the multi‐mutant HIV‐RT. Molecular mechanics/generalized born surface area analysis revealed CMNPD370 binds more strongly to the mutant reverse transcriptase (RT) compared to the wild‐type, as indicated by a more negative total binding free energy (ΔG_bind) of –17697.64 kcal/mol versus –15503.75 kcal/mol. The results demonstrate that our proposed method is feasible, reliable, and effective. Our findings may facilitate the development of novel NNRTIs targeting drug‐resistant strains and offer new insights for identifying natural therapies for HIV.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

HIV Reverse TranscriptaseReverse Transcriptase InhibitorsHIV-1Drug DevelopmentAnti-HIV AgentsMolecular Docking SimulationMolecular Dynamics SimulationHumansAlgorithmsMutationDrug Resistance, ViralHIV Infections

Stichwörter der Autor:innen

CMNPD databaseHIVNNRTIdrug designtreatment

Substanzen

HIV Reverse TranscriptaseReverse Transcriptase Inhibitorsreverse transcriptase, Human immunodeficiency virus 1Anti-HIV Agents

Autor:innen und Institutionen

  • Department of Biotechnology, Quaid-i-Azam University, Islamabad, Pakistan.
  • Department of Chemistry, College of Science, Taif University, Taif, Saudi Arabia.

Zitieren

APA

Zubair, A., Ali, M., & Hessien, M. M. (2026). Computer‐Aided Algorithmic Approaches to Drug Development for Multi‐Mutant HIV‐1 Reverse Transcriptase. Clinical Pharmacology in Drug Development. https://doi.org/10.1002/cpdd.1585

Vancouver

Zubair A, Ali M, Hessien MM. Computer‐Aided Algorithmic Approaches to Drug Development for Multi‐Mutant HIV‐1 Reverse Transcriptase. Clinical Pharmacology in Drug Development. 2026. doi:10.1002/cpdd.1585

BibTeX
@article{Zubair2026,
  author = {Zubair, Akmal and Ali, Muhammad and Hessien, Mahmoud M},
  title = {Computer‐Aided Algorithmic Approaches to Drug Development for Multi‐Mutant HIV‐1 Reverse Transcriptase},
  journal = {Clinical Pharmacology in Drug Development},
  year = {2026},
  doi = {10.1002/cpdd.1585}
}
Kostenlos starten →